Long-Cycle, Low-Dosage HRT Using Esterified Estrogens

A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.

In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

Learn how to prepare for your menopause healthcare visit effectively and make the most out of your time with health care professionals, as advised by experts selected by The Menopause Society.

Actress Kim Cattrall discusses her menopause journey and partnership with Tune In To Menopause, an awareness campaign designed to empower women.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Bayer's OASIS 3 trial affirmsed the safety and efficacy of elinzanetant in reducing moderate to severe vasomotor symptoms, bolstering confidence in its potential as a non-hormonal solution for menopause-related issues.